Anwesha Dey

5.2k total citations · 2 hit papers
40 papers, 2.9k citations indexed

About

Anwesha Dey is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Anwesha Dey has authored 40 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Cell Biology and 9 papers in Oncology. Recurrent topics in Anwesha Dey's work include Hippo pathway signaling and YAP/TAZ (12 papers), Cancer-related Molecular Pathways (6 papers) and Ubiquitin and proteasome pathways (5 papers). Anwesha Dey is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (12 papers), Cancer-related Molecular Pathways (6 papers) and Ubiquitin and proteasome pathways (5 papers). Anwesha Dey collaborates with scholars based in United States, France and Singapore. Anwesha Dey's co-authors include Xaralabos Varelas, Kun‐Liang Guan, David P. Lane, James J. Crawford, Jennie R. Lill, Philamer Calses, Vinay Tergaonkar, Michael F. Summers, Omar Abdel‐Wahab and James Brugarolas and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Anwesha Dey

38 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine

2020 566 citations Anwesha Dey et al. Nature Reviews Drug Discovery profile →
Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities

2019 279 citations Philamer Calses, James J. Crawford et al. Trends in cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anwesha Dey United States	26	1.8k	939	544	525	453	40	2.9k
Fenyong Sun China	29	1.9k 1.0×	582 0.6×	294 0.5×	392 0.7×	963 2.1×	74	2.5k
Simona Mozzetti Italy	23	1.4k 0.8×	580 0.6×	798 1.5×	226 0.4×	403 0.9×	35	2.3k
Kelsie L. Thu Canada	34	2.1k 1.2×	388 0.4×	777 1.4×	684 1.3×	859 1.9×	63	2.9k
Tobias Otto Germany	12	1.7k 0.9×	362 0.4×	800 1.5×	467 0.9×	668 1.5×	19	2.6k
Panayiotis A. Theodoropoulos Greece	29	1.2k 0.7×	342 0.4×	757 1.4×	296 0.6×	426 0.9×	48	2.5k
Laura Moro Italy	23	1.1k 0.6×	408 0.4×	436 0.8×	314 0.6×	225 0.5×	55	2.2k
Leanne de Koning France	27	1.5k 0.8×	257 0.3×	486 0.9×	379 0.7×	445 1.0×	66	2.3k
Yonghe Li United States	35	2.4k 1.3×	574 0.6×	807 1.5×	327 0.6×	715 1.6×	57	3.7k
David Matallanas Ireland	30	2.1k 1.2×	1.1k 1.1×	485 0.9×	137 0.3×	262 0.6×	67	2.9k
Keren Paz United States	21	1.7k 0.9×	701 0.7×	560 1.0×	189 0.4×	329 0.7×	33	2.6k

Countries citing papers authored by Anwesha Dey

Since Specialization

Citations

This map shows the geographic impact of Anwesha Dey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anwesha Dey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anwesha Dey more than expected).

Fields of papers citing papers by Anwesha Dey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anwesha Dey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anwesha Dey. The network helps show where Anwesha Dey may publish in the future.

Co-authorship network of co-authors of Anwesha Dey

This figure shows the co-authorship network connecting the top 25 collaborators of Anwesha Dey. A scholar is included among the top collaborators of Anwesha Dey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anwesha Dey. Anwesha Dey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Song, K S, Christy C. Ong, Jeff Lau, et al.. (2025). KRAS Codon-Specific Mutations Differentially Toggle PI3K Pathway Signaling and Alter Sensitivity to Inavolisib (GDC-0077). Molecular Cancer Therapeutics. 24(12). 1890–1901. 1 indexed citations

Song, Jane Y., Aaron K. Wong, Jason A. Vander Heiden, et al.. (2025). YAP/TAZ activity in PDGFRα-expressing alveolar fibroblasts modulates AT2 proliferation through Wnt4. Cell Reports. 44(5). 115645–115645.

Ghosh, Saheli, Dhananjoy Mondal, Jhilik Roy, et al.. (2024). MWCNT-intercaleated natural hematite-based activable nanocomposite for piezoelectric energy generation and ROS-mediated carcinogenic dye degradation. Journal of Materials Chemistry C. 12(36). 14627–14641. 1 indexed citations

Sims, Jessica, et al.. (2024). Targeting the Hippo pathway in cancer: kidney toxicity as a class effect of TEAD inhibitors?. Trends in cancer. 11(1). 25–36. 8 indexed citations

Zou, Wei, Yongjia Li, Kevin Cho, et al.. (2023). BAP1 promotes osteoclast function by metabolic reprogramming. Nature Communications. 14(1). 5923–5923. 19 indexed citations

Zou, Wei, Nidhi Rohatgi, Jonathan R. Brestoff, et al.. (2020). Myeloid-specific Asxl2 deletion limits diet-induced obesity by regulating energy expenditure. Journal of Clinical Investigation. 130(5). 2644–2656. 13 indexed citations

Hagenbeek, Thijs J., Ho-June Lee, Jason Li, et al.. (2020). Machine-Learning and Chemicogenomics Approach Defines and Predicts Cross-Talk of Hippo and MAPK Pathways. Cancer Discovery. 11(3). 778–793. 37 indexed citations

Chung, Jun-Jae, Leonard D. Goldstein, Ying-Jiun J. Chen, et al.. (2020). Single-Cell Transcriptome Profiling of the Kidney Glomerulus Identifies Key Cell Types and Reactions to Injury. Journal of the American Society of Nephrology. 31(10). 2341–2354. 129 indexed citations

He, Meng, Mira S. Chaurushiya, Joshua D. Webster, et al.. (2019). Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1. Science. 364(6437). 283–285. 71 indexed citations

10.

Calses, Philamer, James J. Crawford, Jennie R. Lill, & Anwesha Dey. (2019). Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities. Trends in cancer. 5(5). 297–307. 279 indexed citations breakdown →

11.

Christie, Alana, Tiffani McKenzie, Nicholas C. Wolff, et al.. (2017). Modeling Renal Cell Carcinoma in Mice: Bap1 and Pbrm1 Inactivation Drive Tumor Grade. Cancer Discovery. 7(8). 900–917. 110 indexed citations

12.

Napolitano, Andrea, Laura Pellegrini, Anwesha Dey, et al.. (2015). Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma. Oncogene. 35(15). 1996–2002. 115 indexed citations

13.

Napolitano, Andrea, Laura Pellegrini, Anwesha Dey, et al.. (2015). Abstract LB-220: Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma. Cancer Research. 75(15_Supplement). LB–220. 3 indexed citations

14.

Pereg, Yaron, Bob Y. Liu, Karen O’Rourke, et al.. (2010). Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. Nature Cell Biology. 12(4). 400–406. 102 indexed citations

15.

Dey, Anwesha, et al.. (2008). ANTIHYPERGLYCEMIC, ANTIHYPERLIPIDEMIC AND ANTIOXIDANT EFFECT OF PHYLLANTHUS RHEEDII ON STREPTOZOTOCIN INDUCED DIABETIC RATS. Iranian journal of pharmaceutical research. 7(1). 53–59. 25 indexed citations

16.

Dey, Anwesha, Vinay Tergaonkar, & David P. Lane. (2008). Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-κB pathways. Nature Reviews Drug Discovery. 7(12). 1031–1040. 130 indexed citations

17.

Dey, Anwesha, et al.. (2008). Hexamethylene Bisacetamide (HMBA) simultaneously targets AKT and MAPK pathway and represses NF-κB activity: Implications for cancer therapy. Cell Cycle. 7(23). 3759–3767. 64 indexed citations

18.

Dey, Anwesha, Ee Tsin Wong, Chit Fang Cheok, Vinay Tergaonkar, & David P. Lane. (2007). R-Roscovitine simultaneously targets both the p53 and NF-κB pathways and causes potentiation of apoptosis: implications in cancer therapy. Cell Death and Differentiation. 15(2). 263–273. 65 indexed citations

19.

Dey, Anwesha, Sheng‐Hao Chao, & David P. Lane. (2007). HEXIM1 and the Control of Transcription Elongation: From Cancer and Inflammation to AIDS and Cardiac Hypertrophy. Cell Cycle. 6(15). 1856–1863. 42 indexed citations

20.

D′Souza, Victoria, et al.. (2004). NMR Structure of the 101-nucleotide Core Encapsidation Signal of the Moloney Murine Leukemia Virus. Journal of Molecular Biology. 337(2). 427–442. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact